ArticleOncology letters2026

Efficacy and safety of rituximab in the treatment of primary central nervous system lymphoma: A meta-analysis and systematic review of 1,388 patients.

Lichaoyue Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.